Fairvalue-Calculator Fairvalue-Calculator
EN DE

Dis-Chem Pharmacies Limited (DCP) Fair Value & Analysis

Healthcare · ZA · Market cap 27.8B ZAC

Price32.89 ZAC
Fair Value24.01 ZAC
Upside-27.0%
Quality96/100
Evidence: High Range 18.01 ZAC – 30.01 ZAC

Fair value as of: Jun 26, 2026

✦ Screen 34,000+ stocks by fair value & quality — free Start the tool →

Analysis

Dis-Chem Pharmacies Limited (DCP) currently trades at 32.89 ZAC, while our model-based Fair Value estimate is 24.01 ZAC — implying the stock looks roughly 27.0% overvalued today. We read business quality at 96/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Dis-Chem Pharmacies Limited (DCP) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 24.01 ZAC versus a price of 32.89 ZAC — about −27% (overvalued). Model-based estimate, not financial advice.
What is the fair value of DCP?
Our 21-model fair value for Dis-Chem Pharmacies Limited is 24.01 ZAC (as of Jun 26, 2026), built from audited fundamentals. The current price is 32.89 ZAC.
What is the quality score of DCP?
Dis-Chem Pharmacies Limited has a Quality Score of 96/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.